Insmed to Host First Quarter 2018 Financial Results Conference Call on Wednesday, May 2, 2018
25 Avril 2018 - 2:00PM
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical
company focused on the unmet needs of patients with rare diseases,
today announced that it will release its first quarter 2018
financial results on Wednesday, May 2, 2018.
Insmed management will host a conference call for investors
beginning at 8:30 a.m. ET on Wednesday, May 2, 2018 to discuss the
financial results and provide a business update.
Shareholders and other interested parties may participate in the
conference call by dialing (844) 707-0669 (domestic) or (703)
639-1223 (international) and referencing conference ID number
4567628. The call will also be webcast live on the internet on the
company's website at www.insmed.com.
A replay of the conference call will be accessible approximately
two hours after its completion through May 9, 2018 by dialing (855)
859-2056 (domestic) or (404) 537-3406 (international) and
referencing conference ID number 4567628. A webcast of the call
will also be archived for 90 days under the Investor Relations
section of the company's website at www.insmed.com.
About Insmed
Insmed Incorporated is a global biopharmaceutical Company
focused on the unmet needs of patients with rare diseases. The
Company's lead product candidate is ALIS, which is in late-state
development for adult patients with treatment refractory NTM lung
disease caused by MAC, which is a rare and often chronic infection
that is capable of causing irreversible lung damage and can be
fatal. Insmed's earlier-stage clinical pipeline includes
INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase
1 with therapeutic potential in non-cystic fibrosis bronchiectasis
and other inflammatory diseases, and INS1009, an inhaled
nanoparticle formulation of a treprostinil prodrug that may offer a
differentiated product profile for rare pulmonary disorders,
including pulmonary arterial hypertension. For more
information, visit www.insmed.com.
Contact:Blaine Davis Insmed Incorporated (908) 947-2841
blaine.davis@insmed.com
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024